Certified by Founder Lodge
Metagenomi
United States - Emeryville, California
START UP
1 Disclosed Funding Rounds $175,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic disease
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 25 ,2022 | Series B | $175,000,000 | |
| February, 07 ,2023 | Series B | $100,000,000 |
PFM Health Sciences
Farallon Capital Management
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
